Effects of probiotics on Toll‑like receptor expression in ulcerative colitis rats induced by 2,4,6‑trinitro‑benzene sulfonic acid - PubMed (original) (raw)
Effects of probiotics on Toll‑like receptor expression in ulcerative colitis rats induced by 2,4,6‑trinitro‑benzene sulfonic acid
Ping Yao et al. Mol Med Rep. 2017 Apr.
Abstract
The present study aimed to investigate the regulatory effect of probiotics on the expression of Toll‑like receptors (TLRs) in an ulcerative colitis (UC) rat model, and to determine the role of probiotics in the underlying mechanisms through which UC develops and progresses in rat models. Rats were randomly allocated to one of the four following groups: i) The healthy control, ii) the model, iii) the Golden bifid treatment group, and iv) the TLR4 monoclonal antibody (TLR4mAb) intervention group. The UC rat model was established using 2,4,6‑trinitro‑benzene sulfonic acid. The general status and histological changes of rats were scored using the disease activity index and the histopathological scoring method, respectively. In these rats, the expression of TLR4 and TLR2 was measured using reverse transcription‑quantitative polymerase chain reaction. The expression of TLR4 and TLR2 in the model group was significantly higher than that in the healthy control group. However, when compared with the model rats, those that received either Golden bifid treatment or TLR4mAb intervention exhibited significantly decreased mRNA expression levels of TLR4 and TLR2 (P<0.05). The development of UC is characterized by an abnormal immune response in the intestines. Probiotics alleviated inflammatory reactions in rats with UC. The underlying mechanism of UC may be associated with the expression of TLRs and the subsequent release of inflammatory cytokines.
Figures
Figure 1.
Hematoxylin and eosin staining of rat colon tissues (magnification, ×100). (A) Healthy control, (B) model group, (C) Golden bifid group and (D) Toll-like receptor 4 monoclonal antibody group.
Figure 2.
Immunohistological examination of TLR4 expression in rat colon (magnification, ×400). (A) Healthy control, (B) model group, (C) Golden bifid group and (D) TLR 4 monoclonal antibody group. TLR 4, Toll-like receptor 4.
Figure 3.
Histopathological scoring of TLR4 expression. A indicates the healthy control, B indicates the model group, C indicates the Golden bifid group and D indicates the TLR4 monoclonal antibody group. *P<0.05 vs. the control, #P<0.05 vs. the model group. TLR4, Toll-like receptor 4.
Figure 4.
mRNA expression levels of TLR4 and TLR2 in each group. A indicates the healthy control, B indicates the model group, C indicates the Golden bifid group and D indicates the TLR4 monoclonal antibody group. *P<0.05 vs. the control, #P<0.05 vs. the model group. TLR4, Toll-like receptor 4; TLR2, Toll-like receptor 2.
Similar articles
- Expression and implication of toll-like receptors TLR2, TLR4 and TLR9 in colonic mucosa of patients with ulcerative colitis.
Tan Y, Zou KF, Qian W, Chen S, Hou XH. Tan Y, et al. J Huazhong Univ Sci Technolog Med Sci. 2014 Oct;34(5):785-790. doi: 10.1007/s11596-014-1353-6. Epub 2014 Oct 16. J Huazhong Univ Sci Technolog Med Sci. 2014. PMID: 25318894 - Impact of probiotics on toll-like receptor 4 expression in an experimental model of ulcerative colitis.
Yang X, Fu Y, Liu J, Ren HY. Yang X, et al. J Huazhong Univ Sci Technolog Med Sci. 2013 Oct;33(5):661-665. doi: 10.1007/s11596-013-1177-9. Epub 2013 Oct 20. J Huazhong Univ Sci Technolog Med Sci. 2013. PMID: 24142717 - Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis.
Guo N, Lv LL. Guo N, et al. Immun Inflamm Dis. 2023 Oct;11(10):e1045. doi: 10.1002/iid3.1045. Immun Inflamm Dis. 2023. PMID: 37904683 Free PMC article. Review.
Cited by
- Impact of Oral Probiotics in Amelioration of Immunological and Inflammatory Responses on Experimentally Induced Acute Diverticulitis.
Soliman MG, Mansour HA, Hassan WA, Shawky E. Soliman MG, et al. Probiotics Antimicrob Proteins. 2023 Oct;15(5):1113-1123. doi: 10.1007/s12602-022-09969-7. Epub 2022 Jul 15. Probiotics Antimicrob Proteins. 2023. PMID: 35838945 Free PMC article. - Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health.
Mazziotta C, Tognon M, Martini F, Torreggiani E, Rotondo JC. Mazziotta C, et al. Cells. 2023 Jan 2;12(1):184. doi: 10.3390/cells12010184. Cells. 2023. PMID: 36611977 Free PMC article. Review. - Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation.
Luo M, Liu Q, Xiao L, Xiong LS. Luo M, et al. J Health Popul Nutr. 2022 May 16;41(1):21. doi: 10.1186/s41043-022-00302-0. J Health Popul Nutr. 2022. PMID: 35578355 Free PMC article. - Probiotic Supplements on Oncology Patients' Treatment-Related Side Effects: A Systematic Review of Randomized Controlled Trials.
Rodriguez-Arrastia M, Martinez-Ortigosa A, Rueda-Ruzafa L, Folch Ayora A, Ropero-Padilla C. Rodriguez-Arrastia M, et al. Int J Environ Res Public Health. 2021 Apr 17;18(8):4265. doi: 10.3390/ijerph18084265. Int J Environ Res Public Health. 2021. PMID: 33920572 Free PMC article. Review.
References
- Zeng Z, Zhu Z, Yang Y, Ruan W, Peng X, Su Y, Peng L, Chen J, Yin Q, Zhao C, et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: A prospective population-based study. J Gastroenterol Hepatol. 2013;28:1148–1153. doi: 10.1111/jgh.12164. - DOI - PubMed
- Wang LS, Li YX, Zhu HM, Zhu ZS, Ma XD. Influence of bifidobacterium DNA on PKC and NF-kappaB in murine macrophages. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007;23:11–13. (In Chinese) - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical